Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | oxoproline | 22202 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 22290 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 22893 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 23293 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 24017 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 24575 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 24626 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 25467 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 25629 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 25732 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 26384 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 26851 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 27754 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 27867 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 27975 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 27994 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 28014 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 28061 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 28211 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 28681 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 28776 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 28945 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 28994 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 29087 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 29168 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 29486 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 29623 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 29776 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 29859 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 29973 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 30205 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 30264 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 30360 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 30408 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 30534 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 30751 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 30761 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 30935 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 30994 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 31189 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 31310 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 31343 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 31404 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 31414 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 31500 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 31500 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 31502 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 31535 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 31955 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 32093 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 32184 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 32197 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 32312 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 32319 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 32548 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 32563 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 32599 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 32628 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 32688 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 32819 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 33082 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 33237 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 33250 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 33402 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 33427 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 33601 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 33717 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 33725 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 33805 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 34011 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 34027 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 34208 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 34239 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 34383 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 34484 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 34569 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 34581 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 34658 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 34664 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 34672 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 34708 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 34714 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 34731 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 34733 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 34814 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 34908 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 34924 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 34925 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 34953 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 35112 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 35184 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 35230 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 35300 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 35328 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 35337 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 35352 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 35391 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 35423 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 35562 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 35589 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 35660 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 35663 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 35739 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 35785 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 35846 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 35900 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 36044 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 36203 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 36290 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 36300 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 36339 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 36368 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 36373 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 36429 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 36485 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 36579 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 36723 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 36848 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 36901 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 36977 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 37003 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 37016 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 37031 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 37094 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 37099 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 37123 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 37133 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 37157 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 37158 | Counts | 70-74 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 37233 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 37326 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 37343 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 37345 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 37420 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 37465 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 37478 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 37541 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 37549 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 37650 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 37663 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 37819 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 37856 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 37981 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 38006 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 38030 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 38066 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 38106 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 38380 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 38412 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 38494 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 38529 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 38551 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 38857 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 38862 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 38873 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 38902 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 38929 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 38934 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 39181 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 39182 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 39551 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 39706 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 39710 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 39710 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 39784 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 39786 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 39804 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 39887 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 39898 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 39962 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 40242 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | oxoproline | 40317 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 40548 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 40887 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 40978 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 40995 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 41050 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 41223 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 41244 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 41256 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 41326 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 41376 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 41435 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 41471 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | oxoproline | 41569 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 41572 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 41612 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 41718 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | oxoproline | 41808 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | oxoproline | 41935 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 41935 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 42115 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 42128 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 42130 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 42168 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 42266 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 42358 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | oxoproline | 42457 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | oxoproline | 42466 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | oxoproline | 42543 | Counts | 60-64 | Male | Current | - |
Return to search page